JP4660487B2 - Cosmetic composition for increasing skin whitening effect - Google Patents
Cosmetic composition for increasing skin whitening effect Download PDFInfo
- Publication number
- JP4660487B2 JP4660487B2 JP2006549140A JP2006549140A JP4660487B2 JP 4660487 B2 JP4660487 B2 JP 4660487B2 JP 2006549140 A JP2006549140 A JP 2006549140A JP 2006549140 A JP2006549140 A JP 2006549140A JP 4660487 B2 JP4660487 B2 JP 4660487B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- whitening
- skin
- cosmetic composition
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000002087 whitening effect Effects 0.000 title claims description 45
- 239000000203 mixture Substances 0.000 title claims description 28
- 239000002537 cosmetic Substances 0.000 title claims description 12
- 230000001965 increasing effect Effects 0.000 title description 4
- 235000002789 Panax ginseng Nutrition 0.000 claims description 21
- 108090000526 Papain Proteins 0.000 claims description 19
- 229940069445 licorice extract Drugs 0.000 claims description 19
- 244000274847 Betula papyrifera Species 0.000 claims description 14
- 235000009113 Betula papyrifera Nutrition 0.000 claims description 14
- 235000009109 Betula pendula Nutrition 0.000 claims description 14
- 235000010928 Betula populifolia Nutrition 0.000 claims description 14
- 235000002992 Betula pubescens Nutrition 0.000 claims description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims description 10
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 5
- 229960000271 arbutin Drugs 0.000 claims description 5
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims description 5
- 229960004705 kojic acid Drugs 0.000 claims description 5
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims description 5
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims description 5
- 235000019155 vitamin A Nutrition 0.000 claims description 5
- 239000011719 vitamin A Substances 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- 229940045997 vitamin a Drugs 0.000 claims description 5
- -1 licorice extract Chemical compound 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 29
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 22
- 230000000694 effects Effects 0.000 description 10
- 239000002552 dosage form Substances 0.000 description 9
- 230000008099 melanin synthesis Effects 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 235000018185 Betula X alpestris Nutrition 0.000 description 4
- 235000018212 Betula X uliginosa Nutrition 0.000 description 4
- 239000004365 Protease Substances 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 235000019834 papain Nutrition 0.000 description 4
- 229940055729 papain Drugs 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000007844 bleaching agent Substances 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000007306 turnover Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 2
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000008417 skin turnover Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000000069 hyperpigmentation Diseases 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003061 melanogenesis Effects 0.000 description 1
- 239000007758 minimum essential medium Substances 0.000 description 1
- 108010001078 naringinase Proteins 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16B—DEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING
- F16B35/00—Screw-bolts; Stay-bolts; Screw-threaded studs; Screws; Set screws
- F16B35/04—Screw-bolts; Stay-bolts; Screw-threaded studs; Screws; Set screws with specially-shaped head or shaft in order to fix the bolt on or in an object
- F16B35/06—Specially-shaped heads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16B—DEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING
- F16B23/00—Specially shaped nuts or heads of bolts or screws for rotations by a tool
- F16B23/0007—Specially shaped nuts or heads of bolts or screws for rotations by a tool characterised by the shape of the recess or the protrusion engaging the tool
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16B—DEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING
- F16B37/00—Nuts or like thread-engaging members
- F16B37/14—Cap nuts; Nut caps or bolt caps
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mechanical Engineering (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本発明は、メラニンの過剰生成を抑制し、且つ皮膚に生成されたメラニンの排出を促進させることによって、美白効果を増進させることができる化粧料組成物に関し、より詳細には、紅参抽出物、白樺抽出物及びパパイン酵素を含有し、皮膚美白成分である甘草抽出物の美白効果を上昇させることができる化粧料組成物に関する。 The present invention relates to a cosmetic composition capable of enhancing the whitening effect by suppressing the excessive production of melanin and promoting the discharge of melanin produced in the skin, and more particularly, red ginseng extract The present invention relates to a cosmetic composition containing white birch extract and papain enzyme and capable of increasing the whitening effect of licorice extract which is a skin whitening component.
皮膚が紫外線に露出されると、人間の皮膚色を決定するメラニン(melanin)が合成され放出され、染みやそばかす、斑点などのような過色素沈着症を誘発し、美容上、良くない結果をもたらすようになる。 When the skin is exposed to ultraviolet rays, melanin, which determines the color of human skin, is synthesized and released, causing hyperpigmentation such as stains, freckles, and spots, resulting in poor cosmetic results. Come to bring.
メラニンが合成される過程は、細胞内のチロシン(tyrosine)を基質にしてチロシナーゼ(tyrosinase)酵素が作用してドパキノン(dopaquinone)を形成し、ドパキノンからメラニンが生成されるメカニズムを有する。したがって、皮膚が黒くなることを防ぐために、メラニン生成過程の中でいずれかの特定過程を阻害することで、メラニン合成自体を減少させる方法が一般的に研究されている。このように開発された美白剤には、コジック酸(kojic acid)、アルブチン、甘草抽出物、ビタミンA及びビタミンCなどが挙げられる。 The process of synthesizing melanin has a mechanism in which intracellular tyrosine is used as a substrate and tyrosinase enzyme acts to form dopaquinone, and melanin is generated from dopaquinone. Therefore, in order to prevent the skin from becoming dark, methods for reducing melanin synthesis itself by inhibiting any specific process in the melanin production process are generally studied. Whitening agents developed in this way include kojic acid, arbutin, licorice extract, vitamin A and vitamin C.
しかしながら、メラニンは、皮膚色を決定する役割のほか、核周辺に帽子のような構造を形成し、紫外線から遺伝子を保護したり、自由ラジカル(free radical)を除去し、細胞内の蛋白質を保護するなど重要な役割を担当している。その結果、メラニン生成自体を過度に抑制することは、皮膚において必要な最小限の役割を行わない可能性があるという問題点がある。 However, melanin not only plays a role in determining skin color, but also forms a hat-like structure around the nucleus, protecting genes from ultraviolet rays, removing free radicals, and protecting intracellular proteins. I am in charge of an important role. As a result, there is a problem that excessive suppression of melanin production itself may not perform the necessary minimum role in the skin.
したがって、過度に生成されたメラニンだけを選択的に速く除去することによって、肌の色合いを明るくするような接近方法が必要であると思われる。 Therefore, it appears that an access method is needed that brightens the skin tone by selectively and quickly removing only the excessively produced melanin.
これより、本発明者らは、前述したような問題点を解決するために、皮膚構造と連係して3つの側面で皮膚美白を増進するために研究した。 Accordingly, the present inventors have studied to promote skin whitening in three aspects in conjunction with the skin structure in order to solve the above-described problems.
その結果、第一に、皮膚の角質層の中で、最外側の細胞の脱離を増進させるために、パパイン酵素を使用し、第二に、細胞成長を促進させるために、紅参抽出物を使用し、第三に、白樺抽出物を使用して荒い皮膚を柔軟にすることによって、全体的に皮膚のターンオーバーメカニズムを極大化し、その結果として、皮膚に美白効果を高めることができることを知見し、本発明を完成するに至った。 As a result, firstly, papain enzyme is used to enhance the detachment of the outermost cells in the stratum corneum of the skin, and secondly, red ginseng extract is used to promote cell growth. And, thirdly, by using white cocoon extract to soften rough skin, the overall skin turnover mechanism can be maximized, and as a result, it can enhance the whitening effect on the skin As a result, the present invention has been completed.
したがって、本発明の目的は、皮膚美白成分の美白効能を極大化させることができる方法を提供することにある。これより、本発明では、皮膚美白成分の美白効能を極大化させることができる組成物として、紅参抽出物、白樺抽出物及びパパイン酵素を含有する化粧料組成物を提供する。 Accordingly, an object of the present invention is to provide a method capable of maximizing the whitening effect of a skin whitening component. Thus, the present invention provides a cosmetic composition containing a red ginseng extract, white birch extract and papain enzyme as a composition capable of maximizing the whitening effect of the skin whitening component.
また、本発明の他の目的は、紅参抽出物、白樺抽出物及びパパイン酵素を含有し、美白成分として甘草抽出物を含有する美白用化粧料組成物を提供することにある。 Another object of the present invention is to provide a whitening cosmetic composition containing a red ginseng extract, white birch extract and papain enzyme, and containing a licorice extract as a whitening component.
本発明は、甘草抽出物、紅参抽出物、白樺抽出物及びパパイン酵素を含有する美白用組成物を提供する。 The present invention provides a whitening composition containing a licorice extract, red ginseng extract, white birch extract and papain enzyme.
本発明に係る前記組成物は、メラニンの過剰生成を抑制し、且つ皮膚に生成されたメラニンの排出を促進させることによって、その結果として、美白効果を増進させることができる化粧料組成物に関し、細胞剥離増進、細胞生成促進及び皮膚柔軟化を通じて皮膚全体のターンオーバーの周期を速くすることができる。 The composition according to the present invention relates to a cosmetic composition capable of enhancing the whitening effect as a result by suppressing the excessive production of melanin and promoting the discharge of melanin produced in the skin. Through the cell detachment promotion, cell generation promotion and skin softening, the turnover cycle of the whole skin can be accelerated.
前記甘草抽出物、紅参抽出物、白樺抽出物及びパパイン酵素は、各々を単独で使用する場合に比べて、同時に使用する場合、美白効果が予想し得ない程度に上昇することを本発明者らが初めて発見した。すなわち、前記成分は、互いに混合して使用することによって、美白効果を極大化することができるものである。これより、本発明者らは、前記甘草抽出物、紅参抽出物、白樺抽出物及びパパイン酵素を含有する美白用組成物を「ホワイトエネルギーコンプレックス」と命名した。 The present inventor shows that the licorice extract, red ginseng extract, white birch extract and papain enzyme increase to an extent that the whitening effect cannot be expected when used simultaneously as compared to the case where each is used alone. Discovered for the first time. That is, the said component can maximize the whitening effect by using a mixture with each other. Accordingly, the present inventors named the whitening composition containing the licorice extract, red ginseng extract, white birch extract and papain enzyme as “white energy complex”.
まず、本発明において、前記甘草抽出物は、メラニン生成抑制用美白活性の主成分として作用する。前記甘草抽出物の含量は、組成物の総重量に対して0.001〜2.0重量%が好ましい。0.001重量%未満の濃度では、美白効果が微小であり、2.0重量%を超過する濃度では、皮膚刺激を誘発するからである。 First, in this invention, the said licorice extract acts as a main component of the whitening activity for melanin production suppression. The content of the licorice extract is preferably 0.001 to 2.0% by weight with respect to the total weight of the composition. This is because the whitening effect is minute at a concentration of less than 0.001% by weight, and skin irritation is induced at a concentration of more than 2.0% by weight.
パパイン酵素は、主として、細胞の脱離を増進させる機能をするが、組成物の総重量に対して0.01〜0.1重量%が好ましい。0.01重量%未満の濃度では、その効果が微小であり、0.1重量%を超過する濃度では、皮膚刺激を誘発するからである。 The papain enzyme mainly functions to promote cell detachment, but is preferably 0.01 to 0.1% by weight based on the total weight of the composition. This is because the effect is insignificant at a concentration of less than 0.01% by weight and induces skin irritation at a concentration exceeding 0.1% by weight.
紅参抽出物は、主として、細胞成長を促進させる役割を担当する。好ましくは、6年根紅参が価格及び効能面において適当である。使用量は、組成物の総重量に対して0.01〜5.0重量%が好ましい。0.01重量%未満の濃度では、効果を期待することが難しく、5.0重量%を超過する濃度では、費用の負担が発生する。 Red ginseng extract is mainly responsible for promoting cell growth. Preferably, 6-year-old red ginseng is suitable in terms of price and efficacy. The amount used is preferably 0.01 to 5.0% by weight based on the total weight of the composition. If the concentration is less than 0.01% by weight, it is difficult to expect the effect, and if the concentration exceeds 5.0% by weight, a cost is incurred.
白樺抽出物は、皮膚の柔軟化に寄与する。使用量は、組成物の総重量に対して0.01〜5.0重量%が好ましい。0.01重量%未満の濃度では、効果を期待することが難しく、5.0重量%を超過する濃度では、刺激を誘発することができる。 Birch extract contributes to skin softening. The amount used is preferably 0.01 to 5.0% by weight based on the total weight of the composition. At concentrations below 0.01% by weight, it is difficult to expect an effect, and at concentrations above 5.0% by weight, irritation can be induced.
前記成分の効能は、前記説明した各々の効能に加えて、互いに混合されて使用されることによって、互いに相乗作用を起こすというさらに大きい効用性がある。 In addition to each of the above-described effects, the effects of the components have a greater utility of causing a synergistic effect by being mixed with each other.
なお、前記美白活性の主成分は、甘草抽出物のほか、コジック酸、アルブチン、ビタミンA、ビタミンCなどを使用することができる。 In addition to licorice extract, kojic acid, arbutin, vitamin A, vitamin C and the like can be used as the main component of the whitening activity.
以下、本発明を詳細に説明する。
今まで開発された美白剤は、メラニン生合成に不可欠な基本的且つ最も重要な役割をする酵素であるチロシナーゼ(tyrosinase)の活性を阻害することで、メラニン量を低減することが大部分であった。このように開発された美白剤は、皮膚刺激を誘発する副作用により使用量が制限され、満足できる美白効果を示すことができる程度に十分な量を使用することが難しいことが実情である。これより、本発明の組成物は、美白効果を示す主な美白成分をそのまま使用しながら、美白効果を高めるために皮膚ターンオーバーの活性を高めるシステムを使用することによって、従来の美白剤より優れた美白効果を示すことができるようにした。
Hereinafter, the present invention will be described in detail.
Most whitening agents developed so far have been able to reduce the amount of melanin by inhibiting the activity of tyrosinase, the basic and most important enzyme essential for melanin biosynthesis. It was. The amount of use of the whitening agent thus developed is limited by the side effects that induce skin irritation, and it is actually difficult to use an amount sufficient to show a satisfactory whitening effect. From this, the composition of the present invention is superior to the conventional whitening agent by using a system that enhances the activity of skin turnover in order to enhance the whitening effect while using the main whitening ingredients showing the whitening effect as they are. The whitening effect can be shown.
皮膚は、大きく、浅い層である表皮(epidermis)と、表皮下のさらに深い層である真皮(dermis)とで構成されていて、真皮の下部には、皮膚下組織(subcutaneous tissue)と呼ばれる別途の結合組織層(皮下組織)が存在する。表皮は、上皮組織(epithelial tissue)で構成されている皮膚の最外側層であって、全て5層で構成されている。具体的には、底部から基底層(basal layer)、棘層(spinous layer)、顆粒層(granular layer)、透明層(clear layer)及び角質層(horny layer)よりなり、底部から続いて新しい細胞を生成し、細胞を押し上げながら角質化した死細胞は徐々に剥離されるようになる。このように皮膚の表皮の底部で新しい細胞が生成され、古くなった細胞を皮膚の外側に押し出し、体外に剥離されるようにする周期をターン−オーバー周期というが、本発明では、このようなターン−オーバー周期を促進することによって、皮膚の表皮に生成されたメラニンが体外に速く排出されることができるようにする。 The skin is composed of a large, shallow epidermis and a deeper dermis (dermis). The lower part of the dermis is called a subcutaneous tissue. There is a connective tissue layer (subcutaneous tissue). The epidermis is the outermost layer of the skin composed of epithelial tissue, and is composed of all five layers. Specifically, it consists of a basal layer, a spinous layer, a granular layer, a transparent layer, a clear layer, and a horny layer from the bottom, followed by new cells from the bottom. The dead cells keratinized while pushing up the cells gradually become detached. A cycle in which new cells are generated at the bottom of the epidermis of the skin and the old cells are pushed out of the skin and separated from the body is called a turn-over cycle. By facilitating a turn-over cycle, melanin produced in the epidermis of the skin can be quickly discharged out of the body.
以下、実施例及び比較例に基づいて、本発明の好適な実施の形態を具体的に説明する。しかしながら、本発明がこれらの実施例に限定されるわけではない。 Hereinafter, preferred embodiments of the present invention will be described in detail based on examples and comparative examples. However, the present invention is not limited to these examples.
<実施例1及び2>美白組成物の製造(ホワイトエネルギーコンプレックス1及び2)
甘草抽出物は、Maruzen Pharmaceuticals Co. Ltd(日本国)のグラブリジンが35%以上含有されたもので、商品名としては、Polyol soluble licorice ext P-T(40)を使用した。
<Examples 1 and 2> Production of whitening composition (white energy complexes 1 and 2)
The licorice extract contains 35% or more of grubridin from Maruzen Pharmaceuticals Co. Ltd (Japan), and used as a product name Polysoluble soluble licorice ext PT (40).
紅参抽出物は、コゼ社の6年根紅参抽出液を酵素分解方法を用いて得たものを使用した。 The red ginseng extract used was obtained by using a 6-year-old red ginseng extract from Koze Co., Ltd. using an enzymatic decomposition method.
〔酵素分解方法〕
紅参抽出液10gを100mlのシトレート緩衝溶液(pH5.5)に溶解させ、これにペニシリウム属から分離したナリンジナーゼ酵素1gを添加し、40℃水浴上で48時間攪拌させながら反応させた。薄層クロマトグラフィーにより周期的に確認し、基質が完全に消失されれば、熱水中で10分間加熱し、反応を終了させた後、反応液は、同量のエーテルで3回抽出し、濃縮した。得られた生成物をシリカゲルコラムクロマトグラフィー(クロロホルム:メタノール=9:1)で分離し、紅参抽出物(収率10.5%)を得た。
[Enzymatic degradation method]
10 g of red ginseng extract was dissolved in 100 ml of citrate buffer solution (pH 5.5), 1 g of naringinase enzyme separated from Penicillium was added thereto, and the mixture was allowed to react for 48 hours while stirring on a 40 ° C. water bath. Check periodically by thin layer chromatography, and if the substrate is completely disappeared, after heating for 10 minutes in hot water to complete the reaction, the reaction solution is extracted three times with the same amount of ether, Concentrated. The obtained product was separated by silica gel column chromatography (chloroform: methanol = 9: 1) to obtain a red ginseng extract (yield 10.5%).
白樺抽出物は、Arch Personal Care Products(米国)社の製品(商品名:whitebirch extract)を購入して使用した。 The white birch extract was purchased from Arch Personal Care Products (USA) (trade name: whitebirch extract).
パパイン酵素は、CPC Wolfgang Muhlbauer GmbH(ドイツ)で製造したRefined papain powderを購入して使用した。 Papain enzyme was purchased from Refined papain powder manufactured by CPC Wolfgang Muhlbauer GmbH (Germany).
前記甘草抽出物、紅参抽出物、白樺抽出物及びパパイン酵素を5:5:10:0.3の割合で混合し、本発明の美白用組成物(ホワイトエネルギーコンプレックス)1を203g製造した(実施例1)。 The licorice extract, red ginseng extract, white birch extract and papain enzyme were mixed at a ratio of 5: 5: 10: 0.3 to produce 203 g of whitening composition (white energy complex) 1 of the present invention ( Example 1).
さらに、前記甘草抽出物、紅参抽出物、白樺抽出物及びパパイン酵素を5:10:20:0.6の割合で混合し、ホワイトエネルギーコンプレックス2を356g製造した(実施例2)。 Further, the licorice extract, red ginseng extract, white birch extract and papain enzyme were mixed at a ratio of 5: 10: 20: 0.6 to produce 356 g of white energy complex 2 (Example 2).
<試験例1>メラニン生成抑制効果測定
人間メラノーマ細胞であるHM3KO細胞(Y. F unasaka, Department of dermatology, Kobe university school of medicine, 5-1 Kusunoki-cho 7-chrome, Chuo-ku, Kobe 650, Japan)を牛胎児血清が10%含有されたMinimum Essential Medium(MEM)に入れ、37℃、5%CO2条件下で培養した。このように培養した細胞を、細胞数が各ウェル(well)当たり3×105となるように、75−ウェルフラスコに分株し、一夜細胞が基壁に付くことを待った。細胞がよく付いたことを確認した後、培地を各々の試験物質が10ppm含有されている新培地に交替した。
<Test Example 1> Measurement of inhibitory effect on melanogenesis HM3KO cells (Y. Funasaka, Department of dermatology, Kobe university school of medicine, 5-1 Kusunoki-cho 7-chrome, Chuo-ku, Kobe 650, Japan) was placed in Minimum Essential Medium (MEM) containing 10% fetal bovine serum and cultured under conditions of 37 ° C. and 5% CO 2 . The cells cultured in this manner were divided into 75-well flasks so that the number of cells was 3 × 10 5 per well, and the cells were waited overnight to attach to the base wall. After confirming that the cells were well attached, the medium was replaced with a new medium containing 10 ppm of each test substance.
試験物質は、下記表1に記載された通り使用した。
対照群には、試験試料を使用せずに、DMSOだけが含有された培地を使用した。
Test substances were used as described in Table 1 below.
In the control group, a medium containing only DMSO was used without using a test sample.
比較のために、前記甘草抽出物、コジック酸、アルブチン、ビタミンA、ビタミンC、紅参抽出物、白樺抽出物及びパパイン酵素を単独で使用する場合と、互いに混合して使用する場合に対する全ての場合の数を組み合わせて試験した。 For comparison, all of the licorice extract, kojic acid, arbutin, vitamin A, vitamin C, red ginseng extract, birch extract and papain enzyme used alone and mixed with each other are used. A combination of case numbers was tested.
このような方法で2日に1度ずつ試料が含有された新培地に交替しつつ、細胞がフラスコに満たされるまで培養した。それから、培養液を除去し、PBSで洗浄した後、1N水酸化ナトリウムで溶解し、500nmで吸光度を測定した後、下記の計算式1に基づいて対照群に対する試料のメラニン生成抑制率を計算し、その結果を表1に表した。 The culture was continued until the cells were filled in the flask while changing to a new medium containing the sample once every two days in this manner. Then, after removing the culture solution, washing with PBS, dissolving with 1N sodium hydroxide, measuring the absorbance at 500 nm, and calculating the inhibition rate of the melanin production of the sample with respect to the control group based on the following calculation formula 1. The results are shown in Table 1.
〔計算式1〕
メラニン生成抑制率(%)
={1−(各試験物質の吸光度/対照群の吸光度)}×100
[Calculation Formula 1]
Melanin production inhibition rate (%)
= {1- (absorbance of each test substance / absorbance of control group)} × 100
表1の結果から、ホワイトエネルギーコンプレックスを構成するパパイン、紅参抽出物、白樺抽出物は、それ自体のメラニン生成阻害率が低いが、甘草抽出物と1つ成分または2つ成分とを組み合わせて使用する場合、美白効果が上昇し、甘草抽出物と前記3つ成分とを全て共に使用する場合、美白効果がさらに高まることを確認することができた。 From the results in Table 1, the papain, red ginseng extract, and white birch extract that make up the white energy complex have a low inhibition rate of their own melanin production. When used, the whitening effect was increased, and when the licorice extract and all the three components were used together, it was confirmed that the whitening effect was further enhanced.
また、既存の美白剤として使用されるコジック酸、アルブチン、ビタミンA、ビタミンCの場合にも、パパイン、紅参抽出物、白樺抽出物を共に使用した時、美白効果がさらに高まることを確認することができた。 Also, in the case of kojic acid, arbutin, vitamin A, and vitamin C used as existing whitening agents, it is confirmed that the whitening effect is further enhanced when papain, red ginseng extract, and birch extract are used together. I was able to.
<試験例2>人体皮膚に対する美白効果試験
健康な10名の男子を対象にして被験者の上腕部に直径1.5cmの孔が6個穿設された不透明テープを貼り付けた後、各被験者の最小紅斑量(Minimal Erythema Dose)の1.5〜2倍程度の紫外線(UVB)を照射し、皮膚の黒化を誘導し、試験物質を塗布した後、2ケ月後にクロマメータ(chroma meter)を用いて皮膚の明暗を測定した。
<Test Example 2> Whitening effect test on human skin After applying an opaque tape with 6 holes of 1.5 cm in diameter to the upper arm of 10 healthy male subjects, Irradiate ultraviolet rays (UVB) 1.5 to 2 times the amount of minimal erythema dose, induce skin darkening, apply test substance, and use chromameter 2 months later The brightness of the skin was measured.
各試験物質は、下記表2に記載の剤型例及び比較剤型例に係る剤型を製造し、一日に2回ずつ(朝、夕方)毎日塗布した。 Each test substance was prepared according to the dosage form examples and comparative dosage form examples shown in Table 2 below, and was applied twice a day (morning and evening) every day.
<剤型例1、2及び比較剤型例1〜4>
下記の剤型は、O/Wローション剤型で、単位は重量%である。下記剤型を製造した後、30℃恒温槽に入れ、翌日に測定した粘度は、7000〜11000cpであり、pH(10%水溶液基準)は、6.5〜7.5であった。
<Dosage Form Examples 1 and 2 and Comparative Dosage Form Examples 1 to 4>
The following dosage forms are O / W lotion dosage forms, and the unit is% by weight. After manufacturing the following dosage form, it was put into a 30 degreeC thermostat, the viscosity measured on the next day was 7000-11000cp, and pH (10% aqueous solution reference | standard) was 6.5-7.5.
〔製造方法〕
(1)油相成分1を加熱(70〜75℃)し、均一に混合した。
(2)水相成分1を加熱(70〜75℃)し、均一に溶解及び混合した。
(3)前記(2)に前記(1)を攪拌しながら温度(70〜75℃)を維持した状態で投入してエマルジョンを製造し、油相成分2及び水相成分2を連続的に投入した後、28〜30℃まで冷却した。
〔Production method〕
(1) Oil phase component 1 was heated (70 to 75 ° C.) and mixed uniformly.
(2) The aqueous phase component 1 was heated (70 to 75 ° C.), and uniformly dissolved and mixed.
(3) The above (2) is stirred while the temperature (70-75 ° C) is maintained while stirring (1) to produce an emulsion, and the oil phase component 2 and the water phase component 2 are continuously charged. And then cooled to 28-30 ° C.
効果の判定は、皮膚の明暗を示す“L”値を求めて決定した(日焼けしない韓国人の皮膚色は、一般的に50〜70の値を示す)。試験物質を塗布して効果がある場合は、L値が次第に増加するようになり、試験物質間の比較は、ΔL値(最終L値−試験物質塗布前の値)で表現した。ΔL値が大きいほど、美白効果が大きい。実験結果によるΔL値を表3にまとめた。 The effect was determined by obtaining an “L” value indicating the lightness and darkness of the skin (the skin color of a Korean who does not tan generally indicates a value of 50 to 70). When the test substance was applied, the L value gradually increased, and the comparison between the test substances was expressed by ΔL value (final L value−value before applying the test substance). The greater the ΔL value, the greater the whitening effect. The ΔL values based on the experimental results are summarized in Table 3.
表3の実験結果を参照すれば、甘草抽出物を単独で使用した比較剤型例1と、パパイン、白樺抽出物、紅参抽出物を甘草抽出物と各々使用した比較剤型例2〜4より、前記2つ成分以上を共に使用した剤型例1〜5において、ΔLの値が高く現れ、特に、3つ成分を共に使用したホワイトエネルギーコンプレックスを含有した剤型例1及び2において、ΔLの値が最も高く現れ、これは、美白効果が相対的にさらに大きいものであることが分かる。 Referring to the experimental results in Table 3, Comparative Formula Type Example 1 using licorice extract alone and Comparative Formula Type Examples 2 to 4 using papain, birch extract and red ginseng extract respectively with licorice extract. Further, in the dosage form examples 1 to 5 using both of the above two components, ΔL appears to be high, and in particular in the dosage form examples 1 and 2 containing the white energy complex using both of the three components, ΔL The value of appears the highest, which indicates that the whitening effect is relatively larger.
また、前記ホワイトエネルギーコンプレックスの量が多いほど、相対的にさらに大きい美白効果があることを確認することができた。 Further, it was confirmed that the larger the amount of the white energy complex, the relatively larger whitening effect was obtained.
以上で説明した通り、本発明の美白用組成物であるホワイトエネルギーコンプレックスを用いて水中油型エマルジョンの化粧料組成物を製造し、美白増進効果を確認した結果、美白効果が増進することを確認することができた。 As described above, the cosmetic composition of the oil-in-water emulsion was manufactured using the white energy complex which is the whitening composition of the present invention, and as a result of confirming the whitening enhancement effect, it was confirmed that the whitening effect was enhanced. We were able to.
Claims (4)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040002910A KR101072133B1 (en) | 2004-01-15 | 2004-01-15 | Skin whitening composition having synergic whitening effect |
PCT/KR2005/000146 WO2005067885A1 (en) | 2004-01-15 | 2005-01-14 | Skin whitening composition having synergic whitening effect |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007517866A JP2007517866A (en) | 2007-07-05 |
JP4660487B2 true JP4660487B2 (en) | 2011-03-30 |
Family
ID=34793252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006549140A Active JP4660487B2 (en) | 2004-01-15 | 2005-01-14 | Cosmetic composition for increasing skin whitening effect |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP4660487B2 (en) |
KR (1) | KR101072133B1 (en) |
CN (1) | CN100459970C (en) |
WO (1) | WO2005067885A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100841276B1 (en) * | 2006-12-18 | 2008-06-25 | 한국식품연구원 | Skin Whitening Composition Containing Ethyl Acetate Fraction of White Ginseng with High Whitening Activity |
WO2009067095A1 (en) * | 2007-11-19 | 2009-05-28 | Stiefel Laboratories, Inc. | Topical cosmetic skin lightening compositions and methods of use thereof |
US9364424B2 (en) | 2007-11-19 | 2016-06-14 | Stiefel Laboratories, Inc. | Topical cosmetic skin lightening compositions and methods of use thereof |
US9241893B2 (en) | 2007-11-19 | 2016-01-26 | Stiefel Laboratories, Inc. | Topical cosmetic skin lightening compositions and methods of use thereof |
JP5414236B2 (en) * | 2008-10-10 | 2014-02-12 | 丸善製薬株式会社 | Anti-inflammatory agent |
US8440237B2 (en) | 2009-04-27 | 2013-05-14 | Mary Kay Inc. | Botanical anti-acne formulations |
KR101382114B1 (en) * | 2009-11-30 | 2014-04-08 | (주)아모레퍼시픽 | Skin external composition containing red ginseng polysaccharide extract |
WO2013096485A1 (en) | 2011-12-19 | 2013-06-27 | Mary Kay Inc. | Combination of plant extracts to improve skin tone |
CN104056036A (en) * | 2013-03-21 | 2014-09-24 | 刘宝英 | Health care composition capable of whitening and removing freckle |
EP3116469B1 (en) * | 2014-03-10 | 2018-10-03 | Mary Kay, Inc. | Skin lightening compositions |
JP6583704B2 (en) * | 2014-09-25 | 2019-10-02 | ポーラ化成工業株式会社 | Screening method for pigmentation improvers |
KR101707107B1 (en) | 2015-05-20 | 2017-02-16 | 주식회사 콧데 | Composition for multi-functional activation comprising Liquiritigenin |
WO2017052242A1 (en) * | 2015-09-23 | 2017-03-30 | (주)아모레퍼시픽 | Lightening composition comprising ginseng-derived exosome-like vesicles |
KR102598793B1 (en) * | 2015-09-23 | 2023-11-07 | (주)아모레퍼시픽 | Composition comprising ginseng derived exosome like vesicles for skin whitening |
KR101682123B1 (en) | 2015-10-12 | 2016-12-02 | (주)솔티패밀리그룹 | Cosmetic composition comprising birch sap and herbal extracts for skin whitening and improvement of skin barrier function, and cosmetic comprising the same |
KR101866742B1 (en) | 2015-11-19 | 2018-06-12 | 대봉엘에스 주식회사 | METHOD FOR PREPARING AN LICORICE EXTRACT OF Nrf-2 ACTIVATOR, AND COSMETIC COMPOSITION COMPRISING THE SAME |
KR102207684B1 (en) | 2019-06-07 | 2021-01-26 | 안준민 | Cosmetic composition for skin whitening comprising black-ginseng fermentation extract |
CN112386548A (en) * | 2020-11-13 | 2021-02-23 | 深圳市薇美经典科技发展有限公司 | Freckle-removing skin-brightening preparation and preparation method thereof |
KR102422661B1 (en) | 2020-12-24 | 2022-07-19 | 제너럴바이오(주) | Composition comprising fermented Glycyrrhiza uralensis extract for inhibitory effects on melanogenesis of B16F10 cells |
KR102566401B1 (en) | 2020-12-30 | 2023-08-14 | 제너럴바이오(주) | a composition comprising Fomitella fraxinea mycelium, Ganoderma applanatum mycelium and Glycyrrhizae uralensis extract for inhibitory effects on melanogenesis of B16F10 cells |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001335498A (en) * | 2000-05-26 | 2001-12-04 | Nippon Flour Mills Co Ltd | Bleaching composition and food and cosmetic comprising the same |
WO2003003996A1 (en) * | 2001-07-04 | 2003-01-16 | Hankook Cosmetics Co., Ltd. | Cosmetic composition containing the extract of mountain ginseng adventitious roots |
JP2003081751A (en) * | 2001-09-07 | 2003-03-19 | Sanburen:Kk | Papaya powder-formulated water-containing cosmetic |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020063877A (en) * | 1999-10-14 | 2002-08-05 | 니신 오일 밀스 가부시키가이샤 | Skin-care agents, skin antiaging agents, whitening agents and external skin preparations |
JP3958968B2 (en) * | 2000-03-31 | 2007-08-15 | 日清オイリオグループ株式会社 | External preparation for skin and whitening agent |
KR100357416B1 (en) * | 2000-08-22 | 2002-10-19 | 오세군 | Compositions of whitening cosmetics containing special herbal extracts |
JP3784730B2 (en) | 2002-02-25 | 2006-06-14 | 株式会社カネボウ化粧品 | Whitening cosmetics |
-
2004
- 2004-01-15 KR KR1020040002910A patent/KR101072133B1/en active IP Right Grant
-
2005
- 2005-01-14 CN CNB2005800023623A patent/CN100459970C/en not_active Expired - Fee Related
- 2005-01-14 JP JP2006549140A patent/JP4660487B2/en active Active
- 2005-01-14 WO PCT/KR2005/000146 patent/WO2005067885A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001335498A (en) * | 2000-05-26 | 2001-12-04 | Nippon Flour Mills Co Ltd | Bleaching composition and food and cosmetic comprising the same |
WO2003003996A1 (en) * | 2001-07-04 | 2003-01-16 | Hankook Cosmetics Co., Ltd. | Cosmetic composition containing the extract of mountain ginseng adventitious roots |
JP2003081751A (en) * | 2001-09-07 | 2003-03-19 | Sanburen:Kk | Papaya powder-formulated water-containing cosmetic |
Also Published As
Publication number | Publication date |
---|---|
CN1909885A (en) | 2007-02-07 |
CN100459970C (en) | 2009-02-11 |
WO2005067885A1 (en) | 2005-07-28 |
KR101072133B1 (en) | 2011-10-10 |
JP2007517866A (en) | 2007-07-05 |
KR20050075115A (en) | 2005-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4660487B2 (en) | Cosmetic composition for increasing skin whitening effect | |
KR101823036B1 (en) | Inhibitor of melanin synthesis and the cosmetic composition containing the same | |
JP5675112B2 (en) | Cosmetic composition for skin whitening containing arctin, arctigenin or a mixture thereof as an active ingredient | |
KR20080025960A (en) | Method for preparing icariside i i and skin whitening composition containing the same | |
TWI480057B (en) | Use of caffeamide derivative | |
CN106456526A (en) | Cosmetic composition for skin whitening and wrinkle alleviation, containing, as active ingredients, white rose extract and gartanin derivative compound isolated therefrom | |
US20040042984A1 (en) | Skin whitening composition containing arbutin and glucosidase as active ingredients | |
CN1794967B (en) | Whitening and antioxidative cosmetic composition containing resveratrol and method for preparing the same | |
EP2585077B1 (en) | Agent for suppressing the formation of abnormal skin cells caused by exposure to light | |
KR20090091505A (en) | Composition for skin whitening containing oxygen dissolving water | |
JPH0925209A (en) | Skin preparation for external use | |
CZ20013339A3 (en) | Composition containing resorcinol derivative | |
JP3117275B2 (en) | Ferulic acid-containing cosmetics | |
US8217074B2 (en) | Use of sargachromenol | |
JP2004203812A (en) | Oral composition and bleaching agent containing the same as essential component | |
JPH01207225A (en) | Cosmetic for hair | |
JP4391612B2 (en) | Skin cosmetics | |
JP2008100953A (en) | Melanogenesis inhibitor and whitening cosmetic | |
JPH06145040A (en) | Melanogenesis-suppressing agent | |
KR20160020253A (en) | Cosmetic or pharmaceutical composition for skin whitening, elasticity, anti-wrinkle, or skin moisturizing comprising atractylenolide I | |
KR20160020242A (en) | Cosmetic or pharmaceutical composition for melanism, elasticity, anti-wrinkle, or skin moisturizing comprising parthenolide | |
JP2002145718A (en) | Cosmetic | |
TWI461223B (en) | Use of magnolia grandiflora l. flower extract for whitening composition | |
JP2011511063A (en) | Skin whitening agent containing platicodine-D | |
JP2010515725A (en) | Skin whitening composition containing artemisinin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080107 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100715 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100817 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101117 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20101214 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20101228 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140107 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4660487 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |